P

Inventor

GUSTAFSON KIRK R

US27 patents
⚠️ This page may combine multiple inventors who share the name “GUSTAFSON KIRK R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

US HEALTH

21 patents
US6245737B1Jun 12, 2001

Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

US HEALTH33 citations96
US5843882ADec 1, 1998

Antiviral proteins and peptides

US HEALTH31 citations96
US5821081AOct 13, 1998

Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides

US HEALTH29 citations96
US5962653AOct 5, 1999

Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum

US HEALTH8 citations82
US5783598AJul 21, 1998

Antiretroviral naphthoquinone compounds compositions and uses thereof

US HEALTH14 citations79
US5869522AFeb 9, 1999

Antiviral naphthoquinone compounds, compositions and uses thereof

US HEALTH13 citations78
US5998587ADec 7, 1999

Anti-cyanovirin antibody

US HEALTH5 citations73
US7144918B2Dec 5, 2006

Biologically active macrolides, compositions, and uses thereof

US HEALTH4 citations72
US5859049AJan 12, 1999

Calanolide and related antiviral compounds, compositions, and uses thereof

US HEALTH7 citations72
US5591770AJan 7, 1997

Calanolide and related antiretroviral compounds, compositions, and uses thereof

US HEALTH10 citations71
US7521475B2Apr 21, 2009

Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

US HEALTH1 citations63
US7205334B2Apr 17, 2007

Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof

US HEALTH1 citations63
US6987096B1Jan 17, 2006

Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof

US HEALTH4 citations62
US6774141B1Aug 10, 2004

Calanolide and related antiviral compounds, compositions, and uses thereof

US HEALTH2 citations61
US5672607ASep 30, 1997

Antiviral naphthoquinone compounds, compositions and uses thereof

US HEALTH1 citations60
US8609716B2Dec 17, 2013

Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

US HEALTH0 citations52
US9139595B2Sep 22, 2015

Biologically active macrolides, compositions, and uses thereof

US HEALTH0 citations51
US7790764B2Sep 7, 2010

Biologically active macrolides, compositions, and uses thereof

US HEALTH0 citations51
US6673830B2Jan 6, 2004

Calanolide and related antiviral compounds, compositions, and uses thereof

US HEALTH0 citations50
US9314448B2Apr 19, 2016

Method of inhibiting ABCG2 and other treatment methods

US HEALTH1 citations47
US10246463B2Apr 2, 2019

Hypoxia-inducible factor 1 (HIF-1) inhibitors

US HEALTH0 citations35

BOYD MICHAEL R

2 patents

HENRICH CURTIS J

2 patents

SAYERS THOMAS JOSEPH

1 patent

THE UNITED STATES OF AMERICA AS RESPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES

1 patent